China makes a new vaccine for HPV, the world’s most common sexually transmitted disease - SupChina
Free

We're a new type of news publication

China news you won't read elsewhere.

Weekly Newsletter

Get a roundup of the most important and interesting stories coming out of China.

Podcasts

Sinica, TechBuzz China, and our 6 other shows are the undisputed champs of China podcasts. Listen now.

Feature Articles

Interactive, web-based deep dives into the real China.

Premium

Join the thousands of executives, diplomats, and journalists that rely on SupChina for daily analysis of the full China story.

Daily Newsletter

All the news, every day. Premium analysis directly from our Editor-in-Chief Jeremy Goldkorn.

24/7 Slack Community

Have China-related questions and want answers? Our Slack community is a place to learn, network, and opine.

Free Live Events & More

Monthly live conference calls with leading experts, free entry to SupChina live events in cities around the world, and more.

"A jewel in the crown of China reporting. I go to it, look for it daily. Why? It adds so much insight into the real China. Essential news, culture, color. I find SupChina superior."
— Max Baucus, former U.S. Ambassador to China

Free

We're a new type of news publication

China news you won't read elsewhere.

Weekly Newsletter

Get a roundup of the most important and interesting stories coming out of China.

Podcasts

Sinica, TechBuzz China, and our 6 other shows are the undisputed champs of China podcasts. Listen now.

Feature Articles

Interactive, web-based deep dives into the real China.

OR… for more in-depth analysis and an online community of China-focused professionals:

Learn About Premium Access Now!
Learn More
Minimize
Learn More
Minimize

China makes a new vaccine for HPV, the world’s most common sexually transmitted disease

Fourteen years ago in 2006, the American pharmaceutical giant Merck & Co. released Gardasil, the first vaccine for human papillomavirus (HPV), the world’s most common viral infection of the reproductive tract which often leads to cervical cancer. That medicine has since become one of the world’s best-selling vaccines.

Last week, China finally approved a domestically produced competitor to Gardasil. Its name is Cecolin, or 馨可宁 xīn kě níng, and as you would expect, its price is significantly lower in China. Cecolin was co-developed by drug maker Innovax (万泰沧海生物技术 wàn tài cāng hǎi shēngwù jìshù) and Xiamen University.

The drug’s release has led to excitement and pride, but also some concerns in China, as What’s on Weibo reports:

While Chinese media emphasize the fact that China is now the third country in the world, after US and UK, to succeed in producing its own HPV vaccine, one of the topics receiving the most attention on Chinese social media is the price of the Cecolin vaccine. Cecolin is currently priced at 329 yuan (US$47) per shot, which is considerably cheaper than the approximate $250 per dose of the Gardasil vaccine in the United States…

But there is also a lot of discussion on the quality of the vaccine, and whether the bivalent vaccine is effective enough (for clarity — the two HPV types the vaccine protects against causes 84.5 percent of all cervical cancers in China). Some Weibo users say they would still like to get the more expensive nonavalent vaccine instead — even if they will need to spend around 4000 yuan ($570) on their completed shots. Other commenters are most concerned with the general availability of HPV vaccines in China, as there is still a shortage of vaccinations.

Share
Lucas Niewenhuis

Lucas Niewenhuis is an associate editor at SupChina who helps curate daily news and produce the company's newsletter, app, and website content. Previously, Lucas researched China-Africa relations at the Social Science Research Council and interned at the Council on Foreign Relations in New York. He has studied Chinese language and culture in Shanghai and Beijing, and is a graduate of the University of Michigan.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.